Company

Sorbent Therapeutics

Sorbent Therapeutics develops therapies and drug delivery systems focused on gastrointestinal health.

About

Sorbent Therapeutics develops therapeutic products and drug delivery systems for gastrointestinal conditions. The company was founded in 2005 and is based in Sunnyvale, US. It raised USD 6.5 mn in Series D funding on May 15, 2014, from investors including ARCH Venture Partners, AgeChem, and Novartis Venture Fund.

8Funding rounds

7Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in